1 Wall Street Analyst Sees Spacex's Stock Soaring by Over 450%. What Are the Chances of It Happening?

SpaceX shares are down ~28% from their IPO-era high, trading just above $145 after an IPO priced at $135 and valuing the company at ~$1.77T. Raymond James set an aggressive $800 target (implying ~452% upside from ~$145), which would require ~19% average annual returns over a decade—an outcome the article views as unlikely given mega-IPO underperformance and hype-driven moves. Overall, the piece is cautionary on near-term upside despite the headline $800 forecast.

Analysis

This is a classic reflexivity setup: a newly public, narrative-heavy name can trade far more on expectation compression than on actual operating progress. When the market capitalizes far-dated optionality this aggressively, every quarter without a visible step-up in monetization shortens the duration multiple and makes the equity behave like a long bond with venture-style uncertainty.

The immediate loser is the incremental buyer of hype; the first-order rebound from analyst enthusiasm is usually weaker than expected because early holders use strength to distribute. The second-order winners are higher-quality growth names and any profitable aerospace/semicapitalization proxies that compete for the same speculative capital, while adjacent space names remain vulnerable to sympathy derating if the flagship cannot hold gains. The main risk to a bearish read is a real operating inflection: faster cash conversion, clearer unit economics, or a strategic contract that proves the optionality is closer to monetization than the market assumes.

Over the next 1-3 months, the tape should be driven by commentary, secondary supply, and any lockup-style overhang rather than fundamental re-rating. Over 6-18 months, the thesis depends on whether the business can turn narrative into compounding FCF; if not, the multiple should continue to compress even if revenue grows. The contrarian miss is that the market is treating the name like a platform monopoly, but the right valuation frame is closer to a call option whose worth is highly sensitive to the discount rate and execution timing.

Key Decisions for Investors

• Fade strength in SPCX via a 3-6 month put spread on any analyst-driven rally; target a 1.5-2.0x premium payoff if the stock reverts toward prior trading ranges. Stop if the next operating update shows clear acceleration in monetization or margin inflection.
• Pair trade: long NVDA / short SPCX, sized beta-neutral, to express quality-duration versus narrative-duration over the next 1-3 months. This works if rates stay firm and investors continue rotating away from unproven optionality; thesis breaks on a broad risk-on melt-up or a genuine SPCX operating surprise.
• If borrow is tight or the name is too illiquid, use a small tactical short only after an upside squeeze rather than initiating into weakness. The best entry is usually post-headline exhaustion, not on the initial move.
• Set a watch item for secondary issuance, insider selling, or any capital raise language over the next 30-90 days; that would be the cleanest catalyst to add to the short. If none appears and operating metrics improve, cover aggressively.